首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1535559

臉部注射劑市場規模- 分產品（膠原蛋白、PMMA微球、透明質酸、肉毒毒素、羥基磷灰石鈣、聚左旋乳酸）、應用（除皺、臉部線條矯正、臉部提升）、最終用途和預測，2024年- 2032

Facial Injectables Market Size - By Product (Collagen, PMMA Microspheres, Hyaluronic Acid, Botulinum Toxin, Calcium Hydroxylapatite, Poly-L-lactic Acid), Application (Wrinkle Reduction, Facial Line Correction, Face Lift), End-use & Forecast, 2024 - 2032

出版日期: 2024年06月03日 | 出版商:

Global Market Insights Inc. | 英文 121 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在影像和注射技術不斷進步的推動下，臉部注射劑市場規模預計從 2024 年到 2032 年複合年成長率將達到 10.3%。

許多公司正在致力於改進影像技術，以提供更精確和準確的臉部解剖學評估，從而提高注射劑的有效性和安全性。注射技術的創新也透過改進針頭設計和注射方法的發展來最大限度地減少不適並最大化結果，以獲得更好的結果。例如，2024 年 7 月，Juvederm 的 Juvederm Skinvive 獲得美國 FDA 批准，這是其首款微滴面部注射劑，旨在提供更精緻、更自然的增強效果，以改善效果。

整個市場分為產品、應用、最終用途和區域。

就產品而言，由於對自然和持久增強的需求不斷增加，到 2032 年，面部注射市場的脂肪注射設備細分市場將顯著成長。最近，人們不斷努力改進脂肪萃取、純化和注射技術，以達到最佳效果。創新還改進了將脂肪順利融入臉部組織的方法，以確保更好的輪廓和體積恢復。

從應用來看，由於消費者對增強唇部體積和輪廓的偏好不斷增加，預計從 2024 年到 2032 年，豐唇領域的臉部注射劑產業佔有率將以顯著的複合年成長率成長。技術進步正在改進用於此目的的注射劑，並改進配方以提供更自然和更持久的效果。注射技術的創新也有助於實現精確和對稱的結果，同時最大限度地減少患者的不適和停工時間。

從地區來看，在名人的影響力、媒體曝光度的增加以及可支配收入的增加的推動下，亞太地區面部注射劑市場規模預計將在 2024 年至 2032 年間呈現利潤豐厚的成長。該地區的媒體報導和名人代言正在推動臉部注射的興趣和接受度，使其在流行文化中更加突出。產品供應和可及性的持續改進也將支持臉部注射劑的持續成長並將其融入主流美容和健康習慣中。

產業生態系統分析
產業影響力
- 成長動力
  - 老年人口不斷增加
  - 臉部注射技術的進步
  - 提高對美容療程的認知與接受度
- 產業陷阱與挑戰
  - 嚴格的監管場景
  - 不良反應的風險
成長潛力分析
技術景觀
監管環境
2023 年定價分析
- 按地區
- 按關鍵人物
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
膠原
聚甲基丙烯酸甲酯（PMMA）微球
透明質酸（HA）
肉毒桿菌毒素
羥基磷灰石鈣 (CaHA)
聚左旋乳酸 (PLLA)
自體脂肪注射
其他產品

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
減少皺紋
臉部線條矯正
豐唇術
臉部提升
痤瘡疤痕治療
脂肪萎縮治療
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫療水療中心
皮膚科診所
醫院
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

AbbVie Inc.
Anika Therapeutics, Inc.
APAX Partners
Bioplus Co., Ltd.
Croma-Pharma GmbH
Galderma SA
Ipsen Pharma
Lutronic Corporation
Medytox
Merz Pharma
Prollenium Medical Technologies
Revance Therapeutics, Inc.
Sinclair
Suneva Medical
Teoxane

簡介目錄

Product Code: 3909

Facial Injectables Market size is projected to record 10.3% CAGR from 2024 to 2032, driven by ongoing technological advancements in imaging and injection techniques.

Numerous companies are working on improving imaging technologies to provide more precise and accurate assessments of facial anatomy for enhancing the effectiveness and safety of injectables. Innovations in injection techniques are also minimizing discomfort and maximizing results with developments for refining needle designs and injection methods for better outcomes. For instance, in July 2024, Juvederm received the U.S. FDA approval for Juvederm Skinvive, its first micro droplet facial injectable designed to provide a more refined and natural-looking enhancement for improved results.

The overall market is segregated into product, application, end-use, and region.

In terms of product, the fat injection devices segment in the facial injectables market will experience significant growth by 2032, due to increasing demand for natural and long-lasting enhancements. Of late, there have been rising efforts on improving techniques for fat extraction, purification, and injection to achieve optimal results. Innovations are also refining the methods used in integrating the fat smoothly into facial tissues for ensuring better contouring and volume restoration.

By application, the facial injectables industry share from the lip augmentation segment is projected to grow at a notable CAGR from 2024 to 2032, driven by increasing consumer preference for enhanced lip volume and contour. Advancements are refining the injectables used for this purpose with improvements in formulations to provide more natural and longer-lasting results. Innovations in injection techniques are also helping in achieving precise and symmetrical outcomes while minimizing discomfort and downtime for patients.

Regionally, the Asia Pacific facial injectables market size is predicted to exhibit lucrative growth between 2024 and 2032, fueled by the influence of celebrities and increased media exposure, alongside rising disposable incomes. Media coverage and celebrity endorsements in the region are driving the interest and acceptance of facial injectables, making them more prominent in popular culture. The ongoing improvements in both product offerings and accessibility will also support the sustained growth and integration of facial injectables into mainstream beauty and wellness routines.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing geriatric population
  - 3.2.1.2 Technological advancements in facial injectables
  - 3.2.1.3 Increasing awareness and acceptance of aesthetic treatments
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory scenario
  - 3.2.2.2 Risk of adverse reactions
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis, 2023
- 3.6.1 By region
- 3.6.2 By key player
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Collagen
5.3 Poly methyl methacrylate (PMMA) microspheres
5.4 Hyaluronic acid (HA)
5.5 Botulinum toxin
5.6 Calcium hydroxylapatite (CaHA)
5.7 Poly-L-lactic acid (PLLA)
5.8 Fat injection
5.9 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Wrinkle reduction
6.3 Facial line correction
6.4 Lip augmentation
6.5 Face lift
6.6 Acne scar treatment
6.7 Lipoatrophy treatment
6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Medical spas
7.3 Dermatology clinics
7.4 Hospitals
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa